Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A group of medical students and fellows at Duke University have shown that if you distract patients’ attention while they are having a prostate biopsy it can (at least to some extent) reduce the likelihood of patient reports of pain and anxiety associated with the procedure.
Filed under: Diagnosis | Tagged: anxiety, Bach, biopsy, Brandenberg, pain | 10 Comments »
A new paper in the European Journal of Cancer suggests that men with prostate cancer are at increased risk for depression, for post-traumatic stress disorder, and for use of antidepressant drugs compared to age-matched controls.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anxiety, depression, post-traumatic stress disorder, risk, Sweden, Treatment | 3 Comments »
The potential of “natural products” as agents to prevent and/or treat prostate cancer (and other forms of cancer) is a topic of constant interest to many patients — even though the available data has demonstrated — at best — a limited effectiveness of almost all such products tested.
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: anxiety, extract, mushroom, mycelium, PSA | 2 Comments »
A Dutch research group has published follow-up data related to their continuing evaluation of anxiety and distress levels among men with low-risk, loocalized prostate cancer who are managed with active surveillance at their institution.
Filed under: Living with Prostate Cancer, Management | Tagged: active surveillance, anxiety, distress | Leave a Comment »
There has been good evidence that older cancer patients report less “distress” than younger cancer patients. However, there has been very little research to date into the distinctions among general distress, anxiety, and depression in aging prostate cancer patients.
Filed under: Living with Prostate Cancer | Tagged: age, anxiety, depression, distress | Leave a Comment »
One of the issues that worries people about active surveillance and other forms of “non-interventional” management for prostate cancer is whether patients will suffer unduly from anxiety and distress while living with “untreated” cancer. We know that there are patients who have been on such protocols long-term who do not; we also know that there [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, anxiety, depression, distress | 6 Comments »
It is well known to readers of The “New” Prostate Cancer InfoLink that androgen deprivation therapy (ADT) is a commonly used form of treatment for patients who experience biochemical recurrence (BCR) after first- or second-line therapy. However, as is also well known, the optimal timing of ADT initiation is uncertain, and earlier initiation of ADT [...]
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation therapy, anxiety, hormone therapy, HRQOL, quality of life | 3 Comments »
Looking through my assorted notes from the meeting this morning after getting home late last night, there are four other poster presentations that are worth commenting on very specifically, and then a general comment that I would add.
Filed under: Management, Treatment | Tagged: abiraterone, active surveillance, anxiety, cost, depression, MDV3100, radical prostatectomy | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site